5psq-075 Safety Profile of Fingolimod in Real World Clinical Practice: A Preliminary Study

doi 10.1136/ejhpharm-2020-eahpconf.392
Full Text
Abstract

Available in full text

Date
Authors
Publisher

British Medical Journal Publishing Group

Related search

Pnd10 - Genius Rwe Study (Fingolimod Real World Evidence Italian Multicenter Observational Study in Multiple Sclerosis)preliminary Results

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Long-Term Safety and Real-World Effectiveness of Fingolimod in Relapsing Multiple Sclerosis

Patient Related Outcome Measures
2017English

The Real-World Effectiveness and Safety of Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients: An Observational Study

PLoS ONE
Multidisciplinary
2017English

A Swiss Real World Best Practice Experience in Three Different Clinical Settings of the 6 Hour Fingolimod First Dose Observation Procedure

BMC pharmacology & toxicology
MedicinePharmacology
2015English

PEARL: A Non-Interventional Study of Real-World Alirocumab Use in German Clinical Practice

Drugs - Real World Outcomes
Pharmacology
2019English

Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting

Journal of Neurology & Neurophysiology
2015English

P.068 Real World Experience With Fingolimod in Canada

Canadian Journal of Neurological Sciences
MedicineNeurology
2017English

Characteristics, Resources Utilization and Safety Profile of Patients With Acute Pain: A European Real World Evidence Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Efficacy, Safety, and Resistance Profile of Osimertinib in T790M Mutation-Positive Non-Small Cell Lung Cancer in Real-World Practice

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy